Lucy Abraham

9PUBLICATIONS
38CO-AUTHORS
Models of care and place of birthTraditional Chinese medicine and treatmentsPharmacogenomicsTraditional, complementary and integrative medicine not elsewhere classifiedMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 10, 2026
Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE.

|Jun 11, 2026
A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US.

|Nov 19, 2025
Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial.

Messoud Ashina, Peter McAllister, Charly Gaul

|Jul 30, 2025
A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine.

Taoufik Alsaadi, Reem Suliman, Jiyue Yang

|Jul 28, 2025
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data.

Stewart J Tepper, Aaron Jenkins, Carl Henriksen

|Nov 27, 2024
Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature review.

Richard B Lipton, Astrid Gendolla, Lucy Abraham

Pageof 2

Frequent Collaborators

3 joint publications

Feng Dai

3 joint publications

Aaron Jenkins

3 joint publications

Karin Hygge Blakeman

2 joint publications

Philip G Conaghan